[EN] 1,5-DIARYL-PYRROLE-3-CARBOXAMIDE DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS<br/>[FR] DERIVES DE 1,5-DIARYL-PYRROLE-3-CARBOXAMIDE ET LEUR UTILISATION EN TANT QUE MODULATEURS DES RECEPTEURS DES CANNABINOIDES
申请人:ASTRAZENECA AB
公开号:WO2004058249A1
公开(公告)日:2004-07-15
The present invention relates to a compound of formula (I) (A chemical formula should be inserted here - please see paper copy enclosed herewith) in which R1 and R2 independently represent phenyl, thienyl or pyridyl each of which is optionally substituted by one, two or three groups represented by Z; and R3 is H, a C1-3alkyl group, a C1-3alkoxymethyl group, trifluoromethyl, a hydroxyC1-3alkyl group, an aminoC1-3alkyl group, C1-3alkoxycarbonyl, carboxy, cyano, carbamoyl, mono or di C1-3alkylcarbamoyl, acetyl, or hydrazinocarbonyl of formula -CONHNRaRb wherein Ra and Rb are as defined for R4 and R5 respectively; X is CO or SO2 ; Y is absent or represents NH optionally substituted by a C1-3alkyl group; R4 and R5 independently represent: a C1-6alkyl group; an (amino)C1-4alkyl- group in which the amino is optionally substituted by one or more C1-3alkyl groups; an optionally substituted non-aromatic C3-15carbocyclic group; a (C3-12cycloalkyl)C1-3alkyl- group; a group -(CH2)r(phenyl )s; naphthyl; anthracenyl; a saturated 5 to 8 membered heterocyclic group containing one nitrogen and optionally one of the following: oxygen, sulphur or an additional nitrogen wherein the heterocyclic group is optionally substituted ;1-adamantylmethyl; a group - (CH2)t Het where Het represents an aromatic heterocycle optionally substituted; or R4 represents H and R5 is as defined above; or R4 and R5 together with the nitrogen atom to which they are attached represent a saturated 5 to 8 membered heterocyclic group; R6 is H, a C1-3alkyl group, a C1-3alkoxymethyl group, trifluoromethyl, a hydroxyC1-3alkyl group, C1-3alkoxycarbonyl, carboxy, cyano, carbamoyl, mono or di C1-3alkylcarbamoyl, acetyl, or hydrazinocarbonyl of formula -CONHNRaRb ; with provisos; to processes for preparing such compounds, to their use in the treatment of obesity, psychiatric and neurological disorders particularly obesity, to methods for their therapeutic use and to pharmaceutical compositions containing them.
本发明涉及一种化合物,其化学式为(I),其中R1和R2分别独立表示苯基,噻吩基或吡啶基,每个基上均可选择性地取代一个、两个或三个由Z表示的基团;R3为H,C1-3烷基基团,C1-3烷氧甲基基团,三氟甲基,羟基C1-3烷基基团,氨基C1-3烷基基团,C1-3烷氧羰基,羧基,氰基,氨基甲酰基,一级或二级C1-3烷基甲酰基,乙酰基或化学式为-CONHNRaRb的肼基,其中Ra和Rb分别定义为R4和R5;X为CO或SO2;Y为空或表示NH,该氮原子可选择性地取代为C1-3烷基基团;R4和R5独立地表示:C1-6烷基基团;(氨基)C1-4烷基基团,其中氨基可选择性地取代为一个或多个C1-3烷基基团;可选择性取代的非芳香性C3-15碳环基团;(C3-12环烷基)C1-3烷基基团;基团-(CH2)r(苯) s;萘基;蒽基;含有一个氮原子并可选择性地含有以下之一的饱和的5到8个成员的杂环基团:氧,硫或另一个氮原子,其中杂环基团可选择性地取代;1-金刚烷基甲基;基团-(CH2)t Het,其中Het表示可选择性取代的芳香性杂环族;或者R4表示H,R5如上所定义;或者R4和R5与它们连接的氮原子一起表示饱和的5到8个成员的杂环基团;R6为H,C1-3烷基基团,C1-3烷氧甲基基团,三氟甲基,羟基C1-3烷基基团,C1-3烷氧羰基,羧基,氰基,氨基甲酰基,一级或二级C1-3烷基甲酰基,乙酰基或化学式为-CONHNRaRb的肼基;但需注意的是,本发明还涉及制备这种化合物的方法,以及它们在肥胖、精神和神经疾病特别是肥胖的治疗中的应用方法和包含它们的制药组合物。